Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;60(14):7582-7586.
doi: 10.1002/anie.202015628. Epub 2021 Feb 25.

Tracing Tumor-Derived Exosomal PD-L1 by Dual-Aptamer Activated Proximity-Induced Droplet Digital PCR

Affiliations

Tracing Tumor-Derived Exosomal PD-L1 by Dual-Aptamer Activated Proximity-Induced Droplet Digital PCR

Bingqian Lin et al. Angew Chem Int Ed Engl. .

Abstract

Tumor-derived exosomal proteins have emerged as promising biomarkers for cancer diagnosis, but the quantitation accuracy is hindered by large numbers of normal cell-derived exosomes. Herein, we developed a dual-target-specific aptamer recognition activated in situ connection system on exosome membrane combined with droplet digital PCR (ddPCR) (TRACER) for quantitation of tumor-derived exosomal PD-L1 (Exo-PD-L1 ). Leveraging the high binding affinity of aptamers, excellent selectivity of dual-aptamer recognition, and the high sensitivity of ddPCR, this method exhibits significant sensitivity and selectivity for tracing tumor-derived Exo-PD-L1 in a wash-free manner. Due to the excellent sensitivity, the level of tumor-derived Exo-PD-L1 detected by TRACER can distinguish cancer patients from healthy donors, and for the first time was identified as a more reliable tumor diagnostic marker than total Exo-PD-L1 . The TRACER strategy holds great potential for converting exosomes into reliable clinical indicators and exploring the biological functions of exosomes.

Keywords: aptamers; exosomes; immunotherapy; proximity ligation assay.

PubMed Disclaimer

Similar articles

Cited by

References

    1. R. Kalluri, V. S. LeBleu, Science 2021, 367, eaau6977.
    1. G. Raposo, W. Stoorvogel, J. Cell Biol. 2013, 200, 373-383.
    1. R. Xu, A. Rai, M. Chen, W. Suwakulsiri, D. W. Greening, R. J. Simpson, Nat. Rev. Clin. Oncol. 2018, 15, 617-638.
    1. None
    1. C. Yang, P. D. Robbins, Clin. Dev. Immunol. 2011, 2011, 842849;

Publication types